321 related articles for article (PubMed ID: 18980578)
1. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
Kantartzis K; Machicao F; Machann J; Schick F; Fritsche A; Häring HU; Stefan N
Clin Sci (Lond); 2009 Mar; 116(6):531-7. PubMed ID: 18980578
[TBL] [Abstract][Full Text] [Related]
2. Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content.
Peter A; Kantartzis K; Machicao F; Machann J; Wagner S; Templin S; Königsrainer I; Königsrainer A; Schick F; Fritsche A; Häring HU; Stefan N
Int J Obes (Lond); 2012 Jun; 36(6):774-82. PubMed ID: 21829161
[TBL] [Abstract][Full Text] [Related]
3. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease.
Kantartzis K; Thamer C; Peter A; Machann J; Schick F; Schraml C; Königsrainer A; Königsrainer I; Kröber S; Niess A; Fritsche A; Häring HU; Stefan N
Gut; 2009 Sep; 58(9):1281-8. PubMed ID: 19074179
[TBL] [Abstract][Full Text] [Related]
4. Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss.
Haupt A; Thamer C; Heni M; Tschritter O; Machann J; Schick F; Machicao F; Häring HU; Staiger H; Fritsche A
Obesity (Silver Spring); 2009 Oct; 17(10):1942-5. PubMed ID: 19629057
[TBL] [Abstract][Full Text] [Related]
5. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.
Stefan N; Hennige AM; Staiger H; Machann J; Schick F; Schleicher E; Fritsche A; Häring HU
Diabetes Care; 2007 May; 30(5):1173-8. PubMed ID: 17259477
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle intervention in individuals with normal versus impaired glucose tolerance.
Schäfer S; Kantartzis K; Machann J; Venter C; Niess A; Schick F; Machicao F; Häring HU; Fritsche A; Stefan N
Eur J Clin Invest; 2007 Jul; 37(7):535-43. PubMed ID: 17576204
[TBL] [Abstract][Full Text] [Related]
7. C825T polymorphism of the G protein beta3 subunit is associated with obesity but not with insulin sensitivity.
Stefan N; Stumvoll M; Machicao F; Koch M; Häring HU; Fritsche A
Obes Res; 2004 Apr; 12(4):679-83. PubMed ID: 15090636
[TBL] [Abstract][Full Text] [Related]
8. Acquired obesity is associated with increased liver fat, intra-abdominal fat, and insulin resistance in young adult monozygotic twins.
Pietiläinen KH; Rissanen A; Kaprio J; Mäkimattila S; Häkkinen AM; Westerbacka J; Sutinen J; Vehkavaara S; Yki-Järvinen H
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E768-74. PubMed ID: 15585588
[TBL] [Abstract][Full Text] [Related]
9. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes.
Kotronen A; Juurinen L; Tiikkainen M; Vehkavaara S; Yki-Järvinen H
Gastroenterology; 2008 Jul; 135(1):122-30. PubMed ID: 18474251
[TBL] [Abstract][Full Text] [Related]
10. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
[TBL] [Abstract][Full Text] [Related]
11. High visceral fat mass and high liver fat are associated with resistance to lifestyle intervention.
Thamer C; Machann J; Stefan N; Haap M; Schäfer S; Brenner S; Kantartzis K; Claussen C; Schick F; Haring H; Fritsche A
Obesity (Silver Spring); 2007 Feb; 15(2):531-8. PubMed ID: 17299127
[TBL] [Abstract][Full Text] [Related]
12. The L162V polymorphism of the peroxisome proliferator activated receptor alpha gene (PPARA) is not associated with type 2 diabetes, BMI or body fat composition.
Silbernagel G; Stefan N; Hoffmann MM; Machicao-Arano F; Machann J; Schick F; Winkelmann BR; Boehm BO; Häring HU; Fritsche A; März W
Exp Clin Endocrinol Diabetes; 2009 Mar; 117(3):113-8. PubMed ID: 18726867
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
[TBL] [Abstract][Full Text] [Related]
14. Metabolic implications of dietary trans-fatty acids.
Dorfman SE; Laurent D; Gounarides JS; Li X; Mullarkey TL; Rocheford EC; Sari-Sarraf F; Hirsch EA; Hughes TE; Commerford SR
Obesity (Silver Spring); 2009 Jun; 17(6):1200-7. PubMed ID: 19584878
[TBL] [Abstract][Full Text] [Related]
15. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
[TBL] [Abstract][Full Text] [Related]
16. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability.
Furler SM; Gan SK; Poynten AM; Chisholm DJ; Campbell LV; Kriketos AD
Obesity (Silver Spring); 2006 Feb; 14(2):228-34. PubMed ID: 16571847
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
[TBL] [Abstract][Full Text] [Related]
18. Insulin action, regional fat, and myocyte lipid: altered relationships with increased adiposity.
Gan SK; Kriketos AD; Poynten AM; Furler SM; Thompson CH; Kraegen EW; Campbell LV; Chisholm DJ
Obes Res; 2003 Nov; 11(11):1295-305. PubMed ID: 14627749
[TBL] [Abstract][Full Text] [Related]
19. [Effects of total glucosides of paeony on enhancing insulin sensitivity and antagonizing nonalcoholic fatty liver in rats].
Zheng LY; Pan JQ; Lv JH
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2385-90. PubMed ID: 19157135
[TBL] [Abstract][Full Text] [Related]
20. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
